Net Cash Provided by (Used in) Operating Activities |
-73.9K |
USD |
+34.9% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
75K |
USD |
-46.4% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
26.2M |
shares |
+33.6% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-16.6K |
USD |
-120% |
Q1 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
16K |
USD |
+24.5% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.19M |
USD |
+6.54% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
1.19M |
USD |
+6.54% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
25M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
19.9M |
USD |
+2.93% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Interest Expense |
103K |
USD |
-56.1% |
Q1 2024 |
Q1 2024 |